The Molecular Epidemiology and Genetic Environment of Carbapenemases Detected in Africa

Microbial Drug Resistance

Volumn 22, Issue 1, 2016, Pages 59-68

  Sekyere, John Osei ^a   Govinden, Usha ^a   Essack, Sabiha ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

ACINETOBACTER BAUMANNII; ALGERIA; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CITROBACTER; EGYPT; ENTEROBACTER CLOACAE; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; KENYA; KLEBSIELLA PNEUMONIAE; LIBYAN ARAB JAMAHIRIYA; MADAGASCAR; MOLECULAR EPIDEMIOLOGY; MOROCCO; NIGERIA; NONHUMAN; PRIORITY JOURNAL; SENEGAL; SOUTH AFRICA; TANZANIA; TUNISIA; AFRICA; GENETICS; GRAM NEGATIVE BACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PLASMID; PROCEDURES;

AFRICA; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; PLASMIDS;

EID: 84954093854     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2015.0053     Document Type: Article

References (96)

1. Abdelaziz, M.O., C. Bonura, A. Aleo, T. Fasciana, and C. Mammina. 2013. NDM-1-and OXA-163-producing Klebsiella pneumoniae isolates in Cairo, Egypt, 2012. J. Glob. Antimicrob. Resist. 1:213-215.
2. Aggoune, N., H. Tali-Maamar, F. Assaous, N. Benamrouche, M. Naim, and K. Rahal. 2014. Emergence of plasmid mediated carbapenemase OXA-48 in a Klebsiella pneumoniae strain in Algeria. J. Glob. Antimicrob. Resist. 2:327-329.
3. Al-Agamy, M.H., N.G. Khalaf, M.M. Tawfick, A.M. Shibl, and A. El Kholy. 2014. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int. J. Infect. Dis. 22:49-54.
4. Al-Agamy, M.H., A.M. Shibl, M.S. Ali, H. Khubnani, H.H. Radwan, and D.M. Livermore. 2014. Distribution of b-lactamases in carbapenem-non-susceptible Acinetobacter baumannii in Riyadh, Saudi Arabia. J. Glob. Antimicrob. Resist. 2:17-21.
5. Al-Agamy, M.H., A.M. Shibl, N.A. Elkhizzi, D. Meunier, J.F. Turton, and D.M. Livermore. 2013. Persistence of Klebsiella pneumoniae clones with OXA-48 or NDM carbapenemases causing bacteraemias in a Riyadh hospital. Diagn. Microbiol. Infect. Dis. 76:214-216.
6. Al-Hassan, L. 2013. Diversity of Acinetobacter baumannii Isolates from Egypt. Department of Medical Microbiology. University of Edinburgh, Edinburgh, United Kingdom, pp. 1-200.
7. Andriamanantena, T.S., E. Ratsima, H.C. Rakotonirina, F. Randrianirina, L. Ramparany, J.F. Carod, V. Richard, and A. Talarmin. 2010. Dissemination of multidrug resistant Acinetobacter baumannii in various hospitals of Antananarivo Madagascar. Ann. Clin. Microbiol. Antimicrob. 9:17.
8. Bakour, S., A.O. Olaitan, H. Ammari, A. Touati, S. Saoudi, K. Saoudi, and J.M. Rolain. 2015. Emergence of colistin-and carbapenem-resistant Acinetobacter baumannii ST2 clinical isolate in Algeria: first case report. Microb. Drug Resist. 21:279-285.
9. Bakour, S., A. Touati, T. Bachiri, F. Sahli, D. Tiouit, M. Naim, M. Azouaou, and J.M. Rolain. 2014. First report of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and rapid spread of metallo-beta-lactamase NDM-1 in Algerian hospitals. J. Infect. Chemother. 20:696-701.
10. Barguigua, A., F. El Otmani, F. Lakbakbi El Yaagoubi, M. Talmi, K. Zerouali, and M. Timinouni. 2013. First report of a Klebsiella pneumoniae strain coproducing NDM-1, VIM-1 and OXA-48 carbapenemases isolated in Morocco. APMIS. 121:675-677.
11. Barguigua, A., F. El Otmani, M. Talmi, K. Zerouali, and M. Timinouni. 2012. Emergence of carbapenemresistant Enterobacteriaceae isolates in the Moroccan community. Diagn. Microbiol. Infect. Dis. 73:290-291.
12. Barguigua, A., F. El Otmani, M. Talmi, K. Zerouali, and M. Timinouni. 2013. Prevalence and types of extended spectrum beta-lactamases among urinary Escherichia coli isolates in Moroccan community. Microb. Pathog. 61-62:16-22.
13. Bathoorn, E., A.W. Friedrich, K. Zhou, J.P. Arends, D.M. Borst, H. Grundmann, and J.W. Rossen. 2013. Latent introduction to the Netherlands of multiple antibiotic resistance including NDM-1 after hospitalisation in Egypt, August 2013. Euro. Surveill. 18:pii-20610.
14. Bellomo, A.N., M.M. Kock, P.E. Makgotlho, A.A. Hoosen, and M.M. Ehlers. 2008. Prevalence of Antibiotic Resistance Genes in Acinetobacter baumannii Isolated from Clinical Specimens from Pretoria Academic Hospital. University of Pretoria Health Sciences Faculty Day, Pretoria, South Africa. Available at http://repository.up.ac.za/ bitstream/handle/2263/7623/bellomo-prevalence-poster.pdf? sequence=1 (Online).
15. Benouda, A., O. Touzani, M.T. Khairallah, G.F. Araj, and G.M. Matar. 2010. First detection of oxacillinasemediated resistance to carbapenems in Klebsiella pneumoniae from Morocco. Ann. Trop. Med. Parasitol. 104:327-330.
16. Bonnin, R., L. Poirel, G. Cuzon, and P. Nordmann. 2013. Transfer of a single New Delhi metallo beta-lactamase-1 (NDM-1)-producing Acinetobacter baumannii clone from North Africa to France. ECCMID Conference. European Society of Clinical Microbiology and Infectious Diseases Berlin, Germany.
17. Brink, A.J., J. Coetzee, C.G. Clay, S. Sithole, G.A. Richards, L. Poirel, and P. Nordmann. 2012. Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa. J. Clin. Microbiol. 50:525-527.
18. Brink, A.J., J. Coetzee, C. Corcoran, C.G. Clay, D. Hari-Makkan, R.K. Jacobson, G.A. Richards, C. Feldman, L. Nutt, and J. van Greune. 2013. Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract. J. Clin. Microbiol. 51:369-372.
19. Centre for Opportunistic Tropical and Hospital Infection (COTHI). 2013. Update on carbapenemase-producing Enterobacteriaceae (CPE). Communicable Dis. Commun. 12:5-6.
20. Charfi-Kessis, K., W. Mansour, A. Ben Haj Khalifa, M. Mastouri, P. Nordmann, M. Aouni, and L. Poirel. 2014. Multidrug-resistant Acinetobacter baumannii strains carrying the blaOxA-23 and the blaGES-11 genes in a neonatology center in Tunisia. Microb. Pathog. 74: 20-24
21. Chibabhai, V., and O. Perovic. 2014. Epidemiology of carbapenem resistant Enterobacteriaceae at Charlotte Maxeke Johannesburg Academic Hospital. Int. J. Infect. Dis. 21, Supplement 1:410.
22. Chika, E., U. Malachy, I. Ifeanyichukwu, E. Peter, G. Thaddeus, and E. Charles. 2014. Phenotypic detection of metallo-b-lactamase (MBL) enzyme in Enugu, Southeast Nigeria. Am. J. Biol. Chem. Pharm. Sci. 2:1-6.
23. Decre, D., G. Birgand, D. Geneste, E. Maury, J.C. Petit, F. Barbut, and G. Arlet. 2010. Possible importation and subsequent cross-transmission of OXA-48-producing Klebsiella pneumoniae, France, 2010. Euro. Surveill. 15:pii 19718.
24. Diene, S.M., B. Fall, M. Kempf, F. Fenollar, K. Sow, B. Niang, B. Wade, D. Raoult, and J.-M. Rolain. 2013. Emergence of the OXA-23 carbapenemase-encoding gene in multidrug-resistant Acinetobacter baumannii clinical isolates from the Principal Hospital of Dakar, Senegal. Int. J. Infect. Dis. 17:e209-e210.
25. El-Din, R.A.A., H. El-Bassat, M. El-Bedewy, and H. El-Mohamady. 2014. Prevalence of metallo-lactamases producers among carbapenem-resistant Acinetobacter baumannii strains isolated from diabetic foot ulcers. Afr. J. Microbiol. Res. 8:1580-1585.
26. el Wartiti, M.A., F.Z. Bahmani, M. Elouennass, and A. Benouda. 2012. Prevalence of carbapenemase-producing Enterobacteriaceae in a University Hospital in Rabat, Morocco: A 19-months prospective study. Int. Arab. J. Antimicrob. Agents 2:1-6.
27. Essack, S.Y. 2001. The development of b-lactam antibiotics in response to the evolution of b-lactamases. Pharm. Res. 18: 1391-1399.
28. Fernández-Cuenca, F., J.M. Rodríguez-Martínez, M.C. Gómez-Sánchez, P.D. de Alba, V. Infante-Martínez, and A . Pascual. 2012. Production of a plasmid-encoded OXA-72 b-lactamase associated with resistance to carbapenems in a clinical isolate Acinetobacter junii. Int. J. Antimicrob. Agents 39:93-94.
29. Fouad, M., A.S. Attia, W.M. Tawakkol, and A.M. Hashem. 2013. Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals. Int. J. Infect. Dis. 17: e1252-e1254.
30. Gales, A.C., M. Castanheira, R.N. Jones, and H.S. Sader. 2012. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn. Microbiol. Infect. Dis. 73:354-360.
31. Girlich, D., N. Bouihat, L. Poirel, A. Benouda, and P. Nordmann. 2014. High rate of faecal carriage of extendedspectrum b-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a University hospital in Morocco. Clin. Microbiol. Infect. 20:350-354.
32. Govender, S. 2013. Detection of Resistance Determinants in Extended-Spectrum Beta-Lactamase-Producing and Carbapenem-Resistant Enterobacteriaceae, Acinetobacter baumanii and Pseudomonas aeruginosa in Port Elizabeth. 5th FIDSSA Conference 2013. South Afr. J. Epidemiol. Infect., Drakensburg, KwaZulu Natal, South Africa, pp. 213.
33. Govind, C.N., K. Moodley, P. Mahabeer, and S. Khan. 2013. The emergence of carbapenem resistant Enterobacteriaceae in KwaZulu Natal, South Africa. 5th FIDSSA Conference 2013, Drakensburg, KwaZulu Natal, South Africa. South Afr. J. Epidemiol. Infect. 28:217.
34. Govind, C.N., K. Moodley, A.K. Peer, N. Pillay, C. Maske, C. Wallis, R. Viana, A. Chetty, and O. Perovic. 2013. NDM-1 imported from India-first reported case in South Africa. South Afr. Med. J. 103:476-478.
35. Hammerum, A.M., A.R. Larsen, F. Hansen, U. Justesen, A. Friis-Moller, L.E. Lemming, K. Fuursted, P. Littauer, K. Schonning, B. Gahrn-Hansen, et al. 2012. Patients transferred from Libya to Denmark carried OXA-48-producing Klebsiella pneumoniae, NDM-1 producing Acinetobacter baumanii and methicillin-resistant Staphylococcus areus. Int. J. Antimicrob. Agents 40:191-192.
36. Hays, C., A. Benouda, L. Poirel, M. Elouennass, and P. Nordmann. 2012. Nosocomial occurrence of OXA-48-producing enterobacterial isolates in a Moroccan hospital. Int. J. Antimicrob. Agents 39:545-547.
37. Hrabák, J., E. Chudáckova, and C.C. Papagiannitsis. 2014. Detection of carbapenemases in Enterobacteriaceae: A challenge for diagnostic microbiological laboratories. Clin. Microbiol. Infect. 20:839-853.
38. Huber, C.A., A.L. Sartor, F. McOdimba, R. Shah, P. Shivachi, H.E. Sidjabat, G. Revathi, and D.L. Paterson. 2014. Outbreaks of multidrug-resistant Acinetobacter baumannii strains in a Kenyan teaching hospital. J. Glob. Antimicrob. Resist. 2:190-193.
39. Kaase, M., P. Nordmann, T.A. Wichelhaus, S.G. Gatermann, R.A. Bonnin, and L. Poirel. 2011. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J. Antimicrob. Chemother. 66:1260-1262.
40. Kaase, M., N. Pfennigwerth, F. Szabados, and S. Gatermann. 2012. OXA-48, OXA-23 and NDM-1 carbapenemases in Gram-negative bacteria form patients from Libya. Clin. Microbiol. Infect. 18:475.
41. Kempf, M., J.-M. Rolain, G. Diatta, S. Azza, B. Samb, O. Mediannikov, A.G. Sow, S.M. Diene, F. Fenollar, and D. Raoult. 2012. Carbapenem resistance and Acinetobacter baumannii in Senegal: The paradigm of a common phenomenon in natural reservoirs. PloS One 7:e39495.
42. Kock, M.M., A.N. Bellomo, N. Storm, and M.M. Ehlers. 2013. Prevalence of carbapenem resistance genes in Acinetobacter baumanii isolated from clinical specimens obtained from an academic hospital in South Africa. South Afr. J. Epidemiol. Infect. 23:28-32.
43. Ktari, S., G. Alert, B. Mnif, V. Gautier, F. Mahjoubi, M. Ben Jemaa, M. Bouaziz, and A. Hammami. 2006. Emergence of multi-drug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended spectrum beta-lactamase and CMY-4 AmpC beta-lactamase in a Tunisian University hospital. Antimicrob. Agents Chemother. 50:4194-4201.
44. Kumarasamy, K.K., M.A. Toleman, and T.R. Walsh. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study. Lancet Infect. Dis. 10:597.
45. Ling, L.L., T. Schneider, A.J. Peoples, A.L. Spoering, I. Engels, B.P. Conlon, A. Mueller, T.F. Schaberle, D.E. Hughes, S. Epstein, et al. 2015. A new antibiotic kills pathogens without detectable resistance. Nature 517:455-459.
46. Livermore, D.M. 2012. Current epidemiology and growing resistance of gram-negative pathogens. Korean J. Intern. Med. 27:128-142.
47. Livermore, D.M., and N. Woodford. 2000. Carbapenemases: A problem in waiting? Curr. Opin. Microbiol. 3: 489-495.
48. Livermore, D.M., and N. Woodford. 2006. The b-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 14:413-420.
49. Lowman, W., M. Marais, K. Ahmed, and L. Marcus. 2014. Routine active surveillance for carbapenemaseproducing Enterobacteriaceae from rectal swabs: diagnostic implications of multiplex polymerase chain reaction. J. Hosp. Infect. 88:66-71.
50. Lowman, W., C. Sriruttan, T. Nana, N. Bosman, A. Duse, J. Venturas, C. Clay, and J. Coetzee. 2011. NDM-1 has arrived: first report of a carbapenem resistance mechanism in South Africa. South Afr. Med. J. 101:873-875.
51. Mansour, W., L. Poirel, D. Bettaieb, O. Bouallegue, N. Boujaafar, and P. Nordmann. 2009. Metallo-b-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia. Diagn. Microbiol. Infect. Dis. 64:458-461.
52. Mesli, E., M. Berrazeg, M. Drissi, S.N. Bekkhoucha, and J.M. Rolain. 2013. Prevalence of carbapenemase-encoding genes including New Delhi metallo-beta-lactamase in Acinetobacter species, Algeria. Int. J. Infect. Dis. 17:e739-e743.
53. Moquet, O., C. Bouchiat, A. Kinana, A. Seck, O. Arouna, R. Bercion, S. Breurec, and B. Garin. 2011. Class D OXA-48 carbapenemase in multidrug-resistant enterobacteria, Senegal. Emerg. Infect. Dis. 17:143-144.
54. Mugnier, P.D., L. Poirel, T. Naas, and P. Nordmann. 2010. Worldwide Dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 16:35.
55. Munoz-Price, L.S., L. Poirel, R.A. Bonomo, M.J. Schwaber, G.L. Daikos, M. Cormican, G. Cornaglia, J. Garau, M. Gniadkowski, M.K. Hayden, et al. 2013. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect. Dis. 13:785-796.
56. Mushi, M.F., S.E. Mshana, C. Imirzalioglu, and F. Bwanga. 2014. Carbapenemase genes among multidrug resistant gram negative clinical isolates from a tertiary hospital in Mwanza, Tanzania. BioMed Res. Int. 2014:1-6.
57. Nordmann, P. 2014. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Méd. Mal. Infect. 44:51-56.
58. Nordmann, P., L. Dortet, and L. Poirel. 2012. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol. Med. 18:263-272.
59. Nordmann, P., D. Girlich, and L. Poirel. 2012. Detection of carbapenemase producers in Enterobacteriaceae using a novel screening medium. J. Clin. Microbiol.50:2761-2766.
60. Nordmann, P., M. Gniadkowski, C. Giske, L. Poirel, N. Woodford, and V. Miriagou. 2012. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin. Microbiol. Infect. 18:432-438.
61. Nordmann, P., and P. Laurent. 2013. Strategies for identification of carbapenemase-producing Enterobacteriaceae. J. Antimicrob. Chemother. 68:487-489.
62. Nordmann, P., T. Naas, and L. Poirel. 2011. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798.
63. Nordmann, P., and L. Poirel. 2014. The difficult-tocontrol spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin. Microbiol. Infect. 20: 821-830.
64. Nordmann, P., L. Poirel, T.R. Walsh, and D.M. Livermore. 2011. The emerging NDM carbapenemases. Trends Microbiol. 19:588-595.
65. Ogbolu, D.O., and M.A. Webber. 2014. High-level and novel mechanisms of carbapenem resistance in Gramnegative bacteria from tertiary hospitals in Nigeria. Int. J. Antimicrob. Agents 43:412-417.
66. Olaitan, A.O., M. Berrazeg, O.E. Fagade, O.O. Adelowo, J.A. Alli, and J.M. Rolain. 2013. Emergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase, Nigeria. Int. J. Infect. Dis. 17: e469-e470.
67. Pirs, M., A. Andlovic, T. Cerar, T. Zohar-Cretnik, I. Kobola, J. Kolman, T. Frelih, M. Presern-Strukelj, E. Ruzic-Sabljic, and K. Seme. 2011. A case of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a patient transferred to Slovenia from Libya, November 2011. Euro. Surveill. 16:20042.
68. Poirel, L., M.O. Abdelaziz, S. Bernabeu, and P. Nordmann. 2013. Occurrence of OXA-48 and VIM-1 carbapenemaseproducing Enterobacteriaceae in Egypt. Int. J. Antimicrob. Agents 41:90-91.
69. Poirel, L., A. Benouda, C. Hays, and P. Nordmann. 2011. Emergence of NDM-1-producing Klebsiella pneumoniae in Morocco. J. Antimicrob. Chemother. 66:2781-2783.
70. Poirel, L., G. Revathi, S. Bernabeu, and P. Nordmann. 2011. Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrob. Agents Chemother. 55:934-936.
71. Potron, A., L. Poirel, F. Bussy, and P. Nordmann. 2011. Occurrence of the carbapenem-hydrolyzing b-lactamase gene blaOXA-48 in the environment in Morocco. Antimicrob. Agents Chemother. 55:5413-5414.
72. Pournaras, S., A. Poulou, E. Voulgari, G. Vrioni, I. Kristo, and A. Tsakris. 2010. Detection of the new metallo-beta-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumoniae. J. Antimicrob. Chemother. 65:1604-1607.
73. Qamar, M.U., A. Hannan, M.U. Arshad, and M. Arshad. 2014. Metallo-b-lactamase producing Enterobacter cloacae: an emerging threat in neonates. Afr. J. Microbiol. Res. 8:525-528.
74. Queenan, A.M., and K. Bush. 2007. Carbapenemases: The versatile b-lactamases. Clin. Microbiol. Rev. 20:440-458.
75. Revathi, G., L.K. Siu, P.-L. Lu, and L.-Y. Huang. 2013. First report of NDM-1-producing Acinetobacter baumannii in East Africa. Int. J. Infect. Dis. 17:e1255-e1258.
76. Robin, F., N. Aggoune-Khinache, J. Delmas, M. Naim, and R. Bonnet. 2010. Novel VIM metallo-b-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria. Antimicrob. Agents Chemother. 54:466-470.
77. Rodriguez-Martinez, J.-M., P. Nordmann, N. Fortineau, and L. Poirel. 2010. VIM-19, a metallo-b-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae. Antimicrob. Agents Chemother. 54:471-476.
78. Rodríguez-Martínez, J.M., C. Velasco, A . Pascual, M.E. Cano, L. Martínez-Martínez, L. Martínez-Martínez, and A . Pascual. 2011. Plasmid-mediated quinolone resistance: an update. J. Infect. Chemother. 17:149-182.
79. Rubin, J.E., G. Peirano, A.K. Peer, C.N. Govind, and J.D.D. Pitout. 2014. NDM-1-producing Enterobacteriaceae from South Africa: moving towards endemicity? Diagn. Microbiol. Infect. Dis. 79:378-380.
80. Ruppe, E., L. Armand-Lefèvre, I. Lolom, A. El Mniai, C.Muller-Serieys, R. Ruimy, P.-L. Woerther, K. Bilariki, M. Marre, P. Massin, et al. 2011. Development of a phenotypic method for detection of fecal carriage of OXA-48-producing Enterobacteriaceae after incidental detection from clinical specimen. J. Clin. Microbiol. 49:2761-2762.
81. Sader, H.S., M. Castanheira, R.E. Mendes, M. Toleman, T.R. Walsh, and R.N. Jones. 2005. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Int. J. Antimicrob. Agents 25:57-61.
82. Seiffert, S.N., J. Marschall, V. Perreten, A. Carattoli, H. Furrer, and A. Endimiani. 2014. Emergence of Klebsiella pneumoniae co-producing NDM-1, OXA-48, CTX-M-15, CMY-16, QnrA and ArmA methyltransferase in Switzerland. Int. J. Antimicrob. Agents 44:260-262.
83. Shibl, A., M. Al-Agamy, Z. Memish, A. Senok, S.A. Khader, and A. Assiri. 2013. The emergence of OXA-48-and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia. Int. J. Infect. Dis. 17:e1130-e1133.
84. Theuretzbacher, U. 2013. Global antibacterial resistance: The never-ending story. J. Glob. Antimicrob. Resist. 1:63-69.
85. Thomas, C.P., L.S.P. Moore, N. Elamin, M. Doumith, J. Zhang, S. Maharjan, M. Warner, C. Perry, J.F. Turton, C. Johnstone, et al. 2013. Early (2008-2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK. Int. J. Antimicrob. Agents 42:531-536.
86. Torres, E., L. López-Cerero, M.D. Del Toro, and A . Pascual. 2013. First detection and characterization of an OXA-48-producing Enterobacter aerogenes isolate. Enferm. Infecc. Microbiol. Clin. 32:469-470.
87. Touati, M., S.M. Diene, A. Racherache, M. Dekhil, A. Djahoudi, and J.M. Rolain. 2012. Emergence of blaOXA-23 and blaOXA-58 carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii isolates from University Hospital of Annaba, Algeria. Int. J. Antimicrob. Agents 40:89-91.
88. Van Boeckel, T.P., S. Gandra, A. Ashok, Q. Caudron, B.T. Grenfell, S.A. Levin, and R. Laxminarayan. 2014. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect. Dis. 14:742-750.
89. Walsh, T.R. 2010. Emerging carbapenemases: A global perspective. Int. J. Antimicrob. Agents 36 Supplement 3:S8-S14.
90. Walther-Rasmussen, J., and N. Holby. 2006. OXA-type carbapenemases. J. Antimicrob. Chemother. 57:373.
91. WHO. 2011. Tackling Antibiotic Resistance from a Food Safety Perspective in Europe. Word Health Organization, WHO-Europe, Denmark, pp. 1-88.
92. WHO. 2014. Antimicrobial Resistance: Global Report on Surveillance. World Health Organisation, France, pp. 1-256.
93. Yamamoto, T., T. Takano, W.-C. Hung, W. Higuchi, Y. Iwao, O. Khokhlova, I. Reva, T. Fusegawa, and T. Shibuya. 2013. Electron microscopic structures, serum resistance, and plasmid restructuring of New Delhi metallob-lactamase-1 (NDM-1)-producing ST42 Klebsiella pneumoniae emerging in Japan. J. Infect. Chemother. 19: 118-127.
94. Yusuf, I., and R.U. Adam. 2014. Adopting Chennai declaration strategies in the prevention and control of the spread of multidrug-resistant hospital-acquired bacterial infections in Nigeria: A call to action. J. Glob. Antimicrob. Resist. 2:203-204.
95. Zander, E., P.G. Higgins, A. Fernández-González, and H. Seifert. 2013. Detection of intrinsic blaOXA-51-like by multiplex PCR on its own is not reliable for the identification of Acinetobacter baumannii. Int. J. Med. Microbiol. 303:88-89.
96. Zerouali, K., A. Barguigua, M. Timinouni, B. Zaki, H. Belabbes, and N. Elmdaghri. 2012. Prevalence and characterization of carbapenemases producing Enterobacteriaceae in a university hospital center Casablanca-Morocco. Clin. Microbiol. Infect. 18:468.